Cholesterol dependence of HTLV-I infection

AIDS Research and Human Retroviruses

Volumn 21, Issue 1, 2005, Pages 43-50

  Wielgosz, Matthew M ^a   Rauch, Daniel A ^a   Jones, Kathryn S ^b   Ruscetti, Frank W ^b   Ratner, Lee ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; CHOLESTEROL; HYBRID PROTEIN; IMMUNOGLOBULIN FC FRAGMENT; RAF PROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS RECEPTOR;

ARTICLE; BINDING AFFINITY; CELL MEMBRANE; CHOLESTEROL BLOOD LEVEL; HUMAN T CELL LEUKEMIA VIRUS 1; LENTIVIRINAE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; VIRUS INFECTION;

ANIMALS; BETA-CYCLODEXTRINS; CELL LINE; CELL MEMBRANE; CHOLESTEROL; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LENTIVIRUS; MEMBRANE MICRODOMAINS; RECEPTORS, VIRUS; TRANSFECTION; VIRAL ENVELOPE PROTEINS; VIRION;

EID: 13144305052     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2005.21.43     Document Type: Article

References (55)

1. Ratner L and Poiesz BJ: Leukemias associated with human T-cell lymphotropic virus type I in a non-endemic region. Medicine 1988;67:401-422.
2. Hollsberg P and Hafler DA: Human T-Cell Lymphotropic Virus Type I. John Wiley & Sons, New York, 1996.
3. Richardson J, Edwards A, Cruicksank J, Rudge P, and Dalgeish A: In vivo cellular tropism of human T-cell leukemia virus type 1. J Virol 1990;64:5682-5687.
4. Jones KS, Nath M, Petrow-Sadowski C, Baines AC, Dambach M, Huang Y, and Ruscetti FW: Similar regulation of cell surface human T-cell leukemia virus type 1 (HTLV-1) surface binding proteins in cells highly and poorly transduced by HTLV-1-pseudotyped virions. J Virol 2002;76:12723-12734.
5. Nath MD, Ruscetti FW, Petrow-Sadowski C, and Jones KS: Regulation of the cell-surface expression of an HTLV-1 binding protein in human T cells during immune activation. Blood 2003;101:1-8.
6. Trejo SR and Ratner L: The HTLV receptor is a widely expressed protein. Virology 2000;268:41-48.
7. Manel N, Kim FJ, Kinet S, Taylor N, Sitbon M, and Battini J-L: The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV. Cell 2003;115:449-459.
8. Niyogi K and Hildreth JEK. Characterization of new syncytium-inhibiting monoclonal antibodies implicates lipid rafts in human T-cell leukemia virus type 1 syncytium formation. J Virol 2001;75:7351-7361.
9. Hague BF, Zhao TM, and Kindt TJ: Binding of HTLV-1 virions to T cell occurs by a temperature and calcium-dependent process and is blocked by certain type 2 adenosine receptor antagonists. Virus Res 2003;93:31-39.
10. Barnes K, Ingram JC, Bennett MD, Stewart GW, and Baldwin SA: Methyl-β-cyclodextrin stimulates glucose uptake in clone 9 cells: A possible role for lipid rafts. Biochem J 2004;378(Pt. 2):343-351.
11. Brown DA and London E: Structure and function of sphingolipid and cholesterol-rich membrane rafts. J Biol Chem 2000;275:17221-17224.
12. Pike LJ: Lipid rafts: Bringing order to chaos. J Lipid Res 2003;44:655-667.
13. Feng X, Vander Heyden N, and Ratner L: Alpha interferon inhibits human T-cell leukemia virus type 1 assembly by preventing Gag interaction with rafts. J Virol 2003;77:13389-13395.
14. Liao Z, Cimakasky LM, Hampton LM, Nguyen R, and Hildreth JEK: Lipid rafts and HIV pathogenesis: Host membrane cholesterol is required for infection by HIV type 1. AIDS Res Hum Retroviruses 2001;17:1009-1019.
15. Nguyen DH and Hildreth JEK: Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J Virol 2000;74:3264-3272.
16. + T cells. J Virol 2002;76:4709-4722.
17. Kimata JT, Wong FH, Wang JJ, and Ratner L: Construction and characterization of infectious human T-cell leukemia virus type 1 molecular clones. Virology 1994;204:656-664.
18. Tsukahara T, Wielgosz MM, and Ratner L: Characterization of envelope glycoprotein mutants for human T-cell leukemia virus type 1 infectivity and immortalization. J Virol 2001;75:9553-9559.
19. Harder T, Scheiffele P, Verkade P, and Simons K: Lipid domain structure of the plasma membrane revealed by patching of membrane components. J Cell Biol 1998;141:929-942.
20. Smart EJ, Graf GA, McNiven MA, Sessa WC, Engelman JA, Scherer PE, Okamoto T, and Lisanti MP: Caveolins, liquid-ordered domains, and signal transduction. Mol Cell Biol 1999;19:7289-7304.
21. Chen Y and Norkin LC: Extracellular simian virus 40 transmits a signal that promotes virus enclosure within caveolae. Exp Cell Res 1999;246:83-90.
22. Dykstra ML, Cherukuri A, and Pierce SK: Floating the raft hypothesis for immune receptors: Access to rafts controls receptor signaling and trafficking. Traffic 2001;2:160-166.
23. Higuchi M, Izumi KM, and Kieff E: Epstein-Bart virus latent-infection membrane proteins are palmitoylated and raft-associated: Protein 1 binds to the cytoskeleton through tumor necrosis factor receptor cytoplasmic factors. Proc Natl Acad Sci USA 2001;98:4675-4680.
24. Vidalain PO, Azocar O, Servet-Delprat C, Rabourdin-Combe C, Gerlier D, and Manie S: CD40 signaling in human dendritic cells is initiated within membrane rafts. EMBO J 2000;19:3304-3313.
25. Campbell SM, Crowe SM, and Mak J: Lipid rafts and HIV-1: From viral entry to assembly of progeny virions. J Clin Virol 2001; 22:217-227.
26. Nayak DP and Barman S: Role of lipid rafts in virus assembly and budding. Adv Virus Res 2002;58:1-28.
27. Shin JS and Abraham SN: Caveolae - not just craters in the cellular landscape. Science 2001;293:1447-1448.
28. van der Goot FG and Harder T: Raft membrane domains: From a liquid-ordered membrane phase to a site of pathogen attack. Semin Immunol 2001;13:89-97.
29. Barman S and Nayak DP: Analysis of the transmembrane domain of influenza virus neuraminidase, a type II transmembrane glycoprotein, for apical sorting and raft association. J Virol 2000;74:6538-6545.
30. Henderson G, Murray J, and Yeo RP: Sorting of the respiratory syncytial virus matrix protein into detergent-resistant structures is dependent on cell-surface expression of the glycoproteins. Virology 2002;300:244-254.
31. Lindwasser OW and Resh MD: Multimerization of human immunodeficiency virus type 1 Gag promotes its localization to barges, raft-like membrane microdomains. J Virol 2001;75:7913-7924.
32. Manie SN, Debreyne S, Vincent S, and Gerlier D: Measles virus structural components are enriched into lipid raft microdomains: A potential cellular location for virus assembly. J Virol 2000; 74:305-311.
33. Sapin C, Colard O, Delmas O, Tessier C, Breton M, Enouf V, Chwetzoff S, Ouanich J, Cohen J, Wolf C, and Trugnan G: Rafts promote assembly and atypical targeting of a nonenveloped virus, rotavirus, in Caco-2 cells. J Virol 2002;76:4591-4602.
34. Scheiffele P, Roth MG, and Simons K: Interaction of influenza virus haemagglutinin with sphingolipid-cholesterol membrane domains via its transmembrane domain. EMBO J 1997;16:5501-5508.
35. Zhang J, Pekosz A, and Lamb RA: Influenza virus assembly and lipid raft microdomains: A role for the cytoplasmic tails of the spike glycoproteins. J Virol 2000;74:4634-4644.
36. Nguyen DH and Hildreth JE: Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J Virol 2000;74:3264-3272.
37. Scheiffele P, Rietveld A, Wilk T, and Simons K: Influenza viruses select ordered lipid domains during budding from the plasma membrane. J Biol Chem 1999;274:2038-2044.
38. Ahn A, Gibbons DL, and Kielian M: The fusion peptide of Semliki Forest virus associates with sterol-rich membrane domains. J Virol 2002;76:3267-3275.
39. Anderson HA, Chen Y, and Norkin LC: Bound simian virus 40 translocates to caveolin-enriched membrane domains, and its entry is inhibited by drugs that selectively disrupt caveolae. Mol Biol Cell 1996;7:1825-1834.
40. Bavari, S, Bosio CM, Wiegand E, Ruthel G, Will AB, Geisbert TW, Hevey M, Schmaljohn C, Schmaljohn A, and Aman MJ: Lipid raft microdomains: A gateway for compartmentalized trafficking of Ebola and Marburg viruses. J Exp Med 2002;195:593-602.
41. Lu X and Silver J: Ecotropic murine leukemia virus receptor is physically associated with caveolin and membrane rafts. Virology 2000;276:251-258.
42. Manes S, del Real G, Lacalle RA, Lucas P, Gomez-Mouton, Sanchez-Palomino S, Delgado R, Alcami J, Mira E, and Martinez AC: Membrane raft microdomains mediate lateral assemblies required for HIV-1 infection. EMBO Rep 2000;1:190-196.
43. Pelkmans L, Kartenbeck J, and Helenius A: Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nat Cell Biol 2001;3:473-483.
44. Stuart AD, Eustace HE, McKee TA, and Brown TD: A novel cell entry pathway for a DAF-with human enterovirus is dependent on lipid rafts. J Virol 2002;76:9307-9322.
45. Favoreel HW, Mettenleiter TC, and Nauwynck HJ: Copatching and lipid raft association of different viral glycoproteins expressed on the surfaces of pseudorabies virus-infected cells. J Virol 2004; 78:5279-5287.
46. Bender FC, Whitbeck JC, Ponce de Leon M, Lou H, Eisenberg RJ, and Cohen GH: Specific association of glycoprotein B with lipid rafts during herpes simplex virus entry. J Virol 2003;77:9542-9552.
47. Triantafilou K and Triantafilou M: Lipid raft microdomains: Key sites for Coxsackievirus A9 infectious cycle. Virology 2003; 317:128-135.
48. Cambi A, De Lange F, Van Maarseveen NM, Nijhuis M, Joosten B, Van Dijk EM, De Bakker BI, Fransen JA, Bovee-Geurts PH, Van Leeuwen FN, Van Hulst NF, and Figdor CG: Microdomains of the C-type lectin DC-SIGN are portals for virus entry into dendritic cells. J Cell Biol 2004;164:145-155.
49. Percherancier Y, Lagane B, Planchenault T, Staropoli I, Altmeyer R, Virelizier J-L, Arenzana-Seisdedos F, Hoessli DC, and Bachelerie F: HIV-1 entry into T-cells is not dependent on CD4 and CCR5 localization to sphingolipid-enriched, detergent-resistant, raft membrane domains. J Biol Chem 2003;278:3153-3161.
50. Narayan S, Barnard RJO, and Young JAT: Two retroviral entry pathways distinguished by lipid raft association of the viral receptor and differences in viral infectivity. J Virol 2003;77:1977-1983.
51. Gagescu R, Demaurex N, Parton RG, Hunziker W, Huber LA, and Gruenberg J: The recycling endosome of Madin-Darby canine kidney cells is a mildly acidic compartment rich in raft components. Mol Biol Cell 2000;11:2775-2791.
52. Lagane B, Gaibelet G, Meilhoc E, Masson J-M, Cezanne L, and Lopez A: Role of sterols in modulating the human mu-opioid receptor function in Saccharomyces cerevisiae. J Biol Chem 2000; 275:33197-33200.
53. Kinet S, Bernard F, Mongellaz C, Perreau M, Goldman FD, and Taylor N: gp120-mediated induction of the MAPK cascade is dependent on the activation state of CD4(+) lymphocytes. Blood 2002;100:2546-2553.
54. Ghez D, Lepelletier Y, et al.: Identification of a cell surface protein behaving as a cellular receptor for HTLV-1 and HTLV-2. AIDS Res Hum Retroviruses 2003;19:S15.
55. Igakura T, Stinchcombe JC, Goon PKC, Taylor GP, Weber JN, Griffiths TM, Tanaka Y, Osame M, and Bangham CRM: Spread of HTLV-1 between lymphocytes by virus-induced polarization of the cytoskeleton. Science 2003;299:1713-1716.